MedPath

Longitudinal Analysis of Drug Burden Index

Completed
Conditions
Cognitive Function
Polypharmacy
Hypnotics and Sedatives
Anticholinergics
Physical Function
Registration Number
NCT03024541
Lead Sponsor
University of Groningen
Brief Summary

Anticholinergic and sedative drugs are frequently prescribed to older people, despite their negative impact on older people's physical and cognitive function. To estimate the cumulative exposure to anticholinergic and sedative drugs, Hilmer et al. published the Drug Burden Index (DBI) in 2007. The present study aims to complement previous study findings showing higher DBI values to be associated with physical and cognitive impairment. Most previously conducted studies of the DBI were either cross-sectional or were longitudinal but with short follow-ups. Furthermore, it remains unknown whether higher DBI values carry extra risks for patients with dementia. Finally, relatively little is known about the stability of DBI values over time. The current project therefore aims to examine (1) longitudinal relationships between long-term cumulative exposure to anticholinergic and sedative drugs as measured with the DBI and cognitive and physical function, (2) to examine interaction effects between DBI exposure and dementia, and (3) to examine trajectories of DBI exposure, i.e. DBI exposure remaining stable, declining, increasing or fluctuating over time. These project aims will be studied with longitudinal data from eligible participants \> 60 years from the LASA study with participants being followed-up during two decades, and the longitudinal data from the InterRAI consortium. Various clinical outcomes regarding cognitive and physical function will be studied. Data will be analysed with generalised linear mixed models and Latent Class Growth Analysis.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
9985
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
LASA study: Alphabet Coding Task21 years: 7 waves separated by 3 year intervals
Secondary Outcome Measures
NameTimeMethod
LASA study: Mini Mental Status Examination21 years: 7 waves separated by 3 year intervals
LASA study: Verbal Fluency Test: Phonemic fluencycollected at 7th wave after 21 years (cross-sectional)
LASA study: 15-Words Test: Word Learning21 years: 7 waves separated by 3 year intervals
LASA study: 15-Words Test: Delayed Recall21 years: 7 waves separated by 3 year intervals
LASA study: Digit Span Forward from Wechsler Adult Intelligence Scalecollected at 7th wave after 21 years (cross-sectional)
LASA study: Chair Stands Test21 years: 7 waves separated by 3 year intervals
LASA study: Walking Test21 years: 7 waves separated by 3 year intervals
LASA study: Balance Test21 years: 7 waves separated by 3 year intervals
LASA study: Verbal Fluency Test: Semantic fluencycollected at 7th wave after 21 years (cross-sectional)
LASA study: Digit Span Backward from Wechsler Adult Intelligence Scalecollected at 7th wave after 21 years (cross-sectional)
LASA study: Functional Independence Scale18 years: 6 waves with 3 year intervals
LASA study: Cardigan Test21 years: 7 waves separated by 3 year intervals
© Copyright 2025. All Rights Reserved by MedPath